Sam-A-Pharm Co Ltd
009300
Company Profile
Business description
Sam-A-Pharm Co Ltd is a South Korea-based company that engages in the manufacturing and selling of pharmaceuticals. The group manufactures respiratory system, antibiotics, skin system, digestive system, antipyretics, analgesics, anti-inflammatory drugs, circulatory endocrine system, general medicines, and health functional foods, and main products include Citus, Codenal, Hebron, Setofen, Tantum, Neocetin, Beforin, Geod-ak, Atok, Ridomex, and Normachu tablets.
Contact
49 Donghwa Industrial Complex-ro
Munmak-eup
Gangwon-do
Wonju-si
KORT: +82 220567200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
314
Stocks News & Analysis
stocks
Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%
We see faster cloud growth and improved longer-term profitability for Alphabet.
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,317.20 | 26.50 | -0.28% |
| CAC 40 | 8,225.63 | 0.15 | -0.00% |
| DAX 40 | 24,239.89 | 32.10 | 0.13% |
| Dow JONES (US) | 47,207.12 | 472.51 | 1.01% |
| FTSE 100 | 9,645.62 | 67.05 | 0.70% |
| HKSE | 26,160.15 | 192.17 | 0.74% |
| NASDAQ | 23,204.87 | 263.07 | 1.15% |
| Nikkei 225 | 49,299.65 | 658.04 | 1.35% |
| NZX 50 Index | 13,391.59 | 14.49 | 0.11% |
| S&P 500 | 6,791.69 | 53.25 | 0.79% |
| S&P/ASX 200 | 9,019.00 | 25.20 | -0.28% |
| SSE Composite Index | 3,950.31 | 27.90 | 0.71% |